-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0710-140625.pdf
January 08, 2014 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
November 19, 2012 - During the Topic Refinement phase of this project, Key Informants
suggested that a review focused on … Method/ (118498)
21 Single
Blind Method/ (17086)
22 clinical trial/
(476450)
23 clinical trial, phase … i.pt. (12809)
24 clinical trial, phase ii.pt. (20505)
25 clinical trial, phase iii.pt. (7571)
26 clinical … trial, phase iv.pt. (759)
27 controlled clinical trial.pt. (85694)
28 randomized controlled trial.pt
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0430_04-22-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Lorcaserin is therefore in
an early diffusion phase. … FDA approved the drug on July 17, 2012, on the basis
of two completed, phase III trials. … Liraglutide is under investigation in a four-part phase III clinical
trial (SCALE). … FDA approved the drug on June 27, 2012, on the basis of three completed phase III trials. … Novo Nordisk reports 8% weight loss in phase 3a
obesity trial with liraglutide 3 mg.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
December 09, 2015 - The McElroy (2014) report on the lisdexamfetamine
Phase 2 trial has been added to the report. … McElroy, APA 2013: this report of the Phase 2 trial was
excluded because it is duplicative to the Phase … This report of the Phase 2 trial was excluded because it
is duplicative to the Phase 2 results presented … 2 and Phase
3)….among individuals with BED.” … We have included the Phase 2 trial in our review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
April 01, 2012 - The enhancements described below will
be incorporated into Phase 2 of our Distributed Research Network … We designated this activity as Phase 1.5,
to distinguish it from the task order that ended in August … Our approach was based on
lessons learned from Phase 1 of DRN and specifically on our findings that … In Phase 1, the prototype demonstrated how participating members can issue queries
through a network … Document Scope
This document describes the functional requirements and design for DRN phase 1.5.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
September 24, 2024 - animals removed
#20 #19 AND ("Controlled Clinical Trial" [Publication Type] OR
"Clinical Trial, Phase … animals removed
#25 #24 AND ("Controlled Clinical Trial" [Publication Type] OR
"Clinical Trial, Phase … animals removed
#30 #29 AND ("Controlled Clinical Trial" [Publication Type] OR
"Clinical Trial, Phase … and NOT animals
#39 #38 AND ("Controlled Clinical Trial" [Publication Type] OR
"Clinical Trial, Phase … IV" [Publication Type] OR "Clinical Trial,
Phase III" [Publication Type] OR "Meta-Analysis" [Publication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_644-03-07-2013.pdf
January 01, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement
phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0272_03-06-2008.pdf
January 01, 2008 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0122_06-29-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0004_03-11-2008.pdf
January 01, 2008 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
March 21, 2013 - to determine
Peer reviewer #5 Executive Summary
ES-12
Table needs to be more specific –luteal phase … The Kaunitz
study (57) is RCT using “luteal phase” or cyclic MPA. … We clarified that “ MPA administered during
the luteal phase of the cycle”
Peer Reviewer #7
(TEP … I f we mean luteal phase progestins or
daily oral or vaginal progestins, that should be stated. … the luteal phase, elevated levels
of systematic estradiol, and associated heavy uterine bleeding.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
January 01, 2009 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0599-131115.pdf
June 20, 2013 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0623-140828.pdf
April 25, 2014 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0658-140831.pdf
July 19, 2014 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0261_07-16-2010.pdf
January 01, 2010 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase